Ultra-precision CRISPR/Cas9 technology platform for selective cleavage of wild-type DNA sequences. Enables targeted amplification of mutant DNA for diagnostic applications. Supports standardized liquid biopsy analysis.
Manufactured by
GeneCker Co., Ltd.
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Synthego
United States · 4 relevant products
Intelligenome
United States · 1 relevant product
Luoyang Geneture Medical Technology Co.,Ltd.
China · 3 relevant products
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 59 closest product alternatives
Synthego · United States
CRISPR-based gene editor that eliminates double-strand breaks for safer therapeutic applications. Provides high-fidelity editing and flexibility for efficient cell and gene therapy development.
Synthego · United States
Engineered high-fidelity Cas9 mRNA for therapeutic genome editing with superior on-target activity and minimal off-target effects. Validated across human cell lines including iPSCs for cell and gene therapy applications.
Synthego · United States
Custom-designed CRISPR gene editors delivered in mRNA format for clinical and research applications. Provides scalable solutions for therapeutic genome editing workflows.
56 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products